⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 9, 2024Neurology

Beyond the Surface, Into the Bloodstream: Should We Test for JAK2 Mutation in ESUS? (P7-5.016)

Prasanna Venkatesan Eswaradass Mohammed Qussay Ali Al-Sabbagh

View Full Paper

Ask AI

Bookmark

Share

Abstract

To present a case of embolic stroke of undetermined source (ESUS) in a patient with a JAK2 mutation, emphasizing the importance of considering myeloproliferative disorders (MPD) in hypercoagulable stroke workup.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Eswaradass et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdadb6db643587677cea https://doi.org/10.1212/wnl.0000000000204524

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1ABSTRACT NUMBER: ESOC2026A2200 HIGH–ALLELE BURDEN JAK2 V617F MUTATION AND EARLY STROKE RECURRENCE IN EMBOLIC STROKE OF UNDETERMINED SOURCECohort Study · 2026
2A-165 JAK2V617F Mutation Prevalence in Thrombophilia Profiles: A Regional Laboratory Experience2025
3JAK2V617F Mutation in Ischemic Stroke: Bridging Hematology and Stroke NeurologyReview · 2026
4ABSTRACT NUMBER: ESOC2026A2171 SEVERE CAROTID T OCCLUSION ISCHEMIC STROKE AS THE FIRST MANIFESTATION OF A JAK2 V617F–ASSOCIATED PROTHROMBOTIC STATERandomized Controlled Trial · 2026
5JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model.Retrospective Study · 2026